Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RPS27 | P42677 | 1/20 | 0.30 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12514583 | 0.91 | ALDH1A1 (0.33) | KDM4EGAAALDH1A1CHEK1KCNH2 | |
| SCHEMBL12363684 | 0.90 | KDM4E (0.32) | KDM4ESQORMAPK1GAANTRK1 | |
| SCHEMBL12363243 | 0.87 | KDM4E (0.30) | KDM4ENTRK1NTRK2MAPTNPSR1 | |
| SCHEMBL12363889 | 0.86 | ATM (0.34) | KDM4EMAPK1GAAALDH1A1MAPT | |
| SCHEMBL12363234 | 0.85 | KDM4E (0.36) | KDM4EMAPK1GAAALDH1A1MAPT | |
| SCHEMBL10105984 | 0.85 | MAPT (0.39) | KDM4EMAPK1GAAALDH1A1MAPT | |
| SCHEMBL12514581 | 0.85 | GAA (0.33) | KDM4EMAPK1GAAALDH1A1MAPT | |
| SCHEMBL10101667 | 0.84 | MAPT (0.31) | KDM4EGAAALDH1A1MAPTNPSR1 | |
| SCHEMBL15958699 | 0.84 | KDM4E (0.51) | KDM4EMAPK1GAAALDH1A1CHEK1 | |
| SCHEMBL10106110 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8808824-B2 | Optical information recording medium, method of recording information and azo metal complex dye | FUJIFILM CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8092890-B2 | Optical information recording medium, method of recording information, and azo metal complex dye | FUJIFILM CORPORATION (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20110202942-A1 | OPTICAL INFORMATION RECORDING MEDIUM, METHOD OF RECORDING INFORMATION AND PHOTOSENSITIZER | FUJIFILM CORPORATION (JP) | 2011-08-18 | — | — | US | disclosed |
| US-20110177281-A1 | OPTICAL INFORMATION RECORDING MEDIUM, METHOD OF RECORDING INFORMATION AND AZO METAL COMPLEX DYE | FUJIFILM CORPORATION (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20080254252-A1 | OPTICAL INFORMATION RECORDING MEDIUM, METHOD OF RECORDING INFORMATION, AND AZO METAL COMPLEX DYE | FUJIFILM CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110202942-A1 | OPTICAL INFORMATION RECORDING MEDIUM, METHOD OF RECORDING INFORMATION AND PHOTOSENSITIZER | KCNN4, IK, KCNJ2 | KDM4E 2051/4885SQOR 673/4885MAPK1 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.